ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
tamsulosin viatris (tamsulosin mylan 0,4 mg hart hylki með breyttan losunarhraða) hart hylki með breyttan losunarhraða 0,4 mg
viatris limited - tamsulosinum hýdróklóríð - hart hylki með breyttan losunarhraða - 0,4 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
dutasteride/tamsulosin teva (dutasteride/tamsulosinehydrochloride teva) hart hylki 0,5 mg/0,4 mg
teva b.v.* - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5 mg/0,4 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
tamsulosin medical (tamsulijn) hart hylki með breyttan losunarhraða 0,4 mg
medical ehf. - tamsulosinum hýdróklóríð - hart hylki með breyttan losunarhraða - 0,4 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
soltamcin tafla með breyttan losunarhraða 6 mg/0,4 mg
williams & halls ehf. - solifenacinum súkkínat; tamsulosinum hýdróklóríð - tafla með breyttan losunarhraða - 6 mg/0,4 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
duta tamsaxiro hart hylki 0,5/0,4 mg
medical valley invest ab - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg
สหภาพยุโรป -
ไอซ์แลนด์ -
EMA (European Medicines Agency)
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
dutaprostam hart hylki 0,5/0,4 mg
zentiva k.s.* - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
duodart hart hylki 0,5/0,4 mg
glaxosmithkline pharma a/s - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
omnic hart hylki með breyttan losunarhraða 0,4 mg
astellas pharma a/s* - tamsulosinum hýdróklóríð - hart hylki með breyttan losunarhraða - 0,4 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
dutasteride medical valley mjúkt hylki 0,5 mg
medical valley invest ab - dutasteridum inn - mjúkt hylki - 0,5 mg